Jump to content

JWH-307

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 46.118.214.13 (talk) at 07:21, 3 November 2010. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

JWH-307
Legal status
Legal status
  • In general: legal
Identifiers
  • (5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC26H24FNO
Molar mass385.472 g/mol g·mol−1
3D model (JSmol)
  • CCCCCN1C=C(C=C1C2=CC=CC=C2F)C(=O)C3=CC=CC4=CC=CC=C43

JWH-307 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors. It is somewhat selective for the CB2 subtype, with a Ki of 7.7nM at CB1 vs 3.3nM at CB2.[1] It was discovered by, and named after, Dr. John W. Huffman.

References

  1. ^ Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorganic & Medicinal Chemistry Letters 2006; 16:5432-5435.

Manufacture and Sale